Articles published by Regeneron Pharmaceuticals, Inc.
Regeneron Reports Third Quarter 2024 Financial and Operating Results
October 31, 2024
Via GlobeNewswire
Tickers
REGN
Regeneron to Highlight Progress Across Its Differentiated Oncology Portfolio and Pipeline at WCLC and ESMO
September 09, 2024
Via GlobeNewswire
Tickers
REGN
Via GlobeNewswire
Tickers
REGN
Via GlobeNewswire
Tickers
REGN
Via GlobeNewswire
Tickers
REGN
Via GlobeNewswire
Tickers
REGN
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|